Report Overview:
The Neurointervention Flow-diverting Stent market refers to the segment of the medical device industry that focuses on devices designed to treat complex aneurysms in the brain. These stents are specially designed to guide blood flow away from the aneurysm site, promoting the clotting of blood within the aneurysm and eventually leading to its natural disappearance. Flow-diverting stents are used in neurointervention procedures, which involve minimally invasive methods to address various neurological conditions, particularly those related to brain aneurysms. These devices are placed in blood vessels to restore proper flow patterns, prevent the rupture of aneurysms, and improve patient outcomes in complex cases where traditional treatment options may not be suitable.
Market Value:
The global Neurointervention Flow-diverting Stent market was valued at approximately USD 436 million in 2024. With a projected compound annual growth rate (CAGR) of 6.40%, the market size is expected to reach USD 762.01 million by 2032.
By Types:
• Recyclable
• Not Recyclable
By Applications: Hospital
Clinic
Key players include:
• Medtronic
• Balt
• Stryker
• MicroVention
• Phenox GmbH
• MicroPort NeuroTech
• Including or Excluding key companies relevant to your analysis.
